Author:
Alshahrouri Bayan,Yang Fengyuan,Schwing Quyen,Dürig Thomas,Fassihi Reza
Reference35 articles.
1. Breakthrough therapies in B-cell non-Hodgkin lymphoma;Altman;Ann. Oncol. [Internet].,2016
2. Ayyappan, S., Maddocks, K., 2019. Novel and emerging therapies for B cell lymphoma. 3, 1–13.
3. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs;Baghel;J. Pharm. Sci. [Internet].,2016
4. Melt extrusion with poorly soluble drugs – An integrated review;Bhagurkar;Int. J. Pharm. [Internet].,2017
5. Ibrutinib (PCI-32765), the first BTK (Bruton’s tyrosine kinase) inhibitor in clinical trials;Brown;Curr. Hematol. Malig. Rep.,2013
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献